Screening for Congenital Critical Heart Disease in Neonates Using Pulse Oximetry, Hospital Femap Ciudad Juarez

Abstract

Objective. The objective of this research was to detect cases of newborns at risk of congenital critical heart disease through neonatal cardiac screening tests using the instrument called "pulse oximeter" manufactured by Masimo SET, as part of the collaboration between the Newborn Foundation, the Autonomous University of Ciudad Juarez and the Autonomous University of Queretaro. Method. A total of 547 newborns were screened from December 2019 to March 2021 at Femap Hospital (Ciudad Juarez, Mexico), following the Newborn Foundation algorithm to detect arterial oxygen saturation (SpO2) in the right hand and foot; a saturation lower than 95% would be an indicator of heart disease risk.